跳至主要内容
临床试验/NCT01284543
NCT01284543Unknown不适用

Randomized Prospective Study Comparing Tan EndoGlide With the Busin Glide for Insertion of the Donor Graft in Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
42
试验地点
2
主要终点
Endothelial cell counts at 1, 3, 6 and 12 months postoperatively

研究概览

简要总结

The Tan EndoGlide device results in less endothelial cell trauma during insertion of the donor corneal graft indicated by reduced endothelial cell loss at 1 year follow-up compared to the Busin glide.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting with corneal decompensation requiring DSAEK with or without cataract surgery for visual rehabilitation.
  • Clinical diagnosis include endothelial cell dysfunction secondary to Fuchs endothelial dystrophy, pseudophakic or aphakic bullous keratopathy, failed penetrating keratoplasty or DSAEK, iridocorneal endothelial syndrome or trauma.
  • Ability to understand the nature of the procedure and give full informed consent.
  • Patients who are able to comply with the standard DSAEK follow-up protocol at the Toronto Western Hospital.

排除标准

  • Patients with late stage corneal decompensation with stromal scarring unsuitable for DSAEK and therefore requiring penetrating keratoplasty.
  • Patients with complex anterior segment pathology precluding successful DSAEK procedure.
  • Patients not giving full informed consent to participate in the trial

结局指标

主要结局

Endothelial cell counts at 1, 3, 6 and 12 months postoperatively

时间窗: 1 year

Best corrected visual acuity at 1, 3, 6, and 12 months postoperatively

时间窗: 1 year

次要结局

  • Complications of surgery(1 year)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验